ASTH vs. SEZL, FTDR, STNE, HRI, GLOB, CNXC, HNGE, WNS, RELY, and CARG
Should you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include Sezzle (SEZL), Frontdoor (FTDR), StoneCo (STNE), Herc (HRI), Globant (GLOB), Concentrix (CNXC), Hinge Health (HNGE), WNS (WNS), Remitly Global (RELY), and CarGurus (CARG). These companies are all part of the "business services" industry.
Astrana Health vs. Its Competitors
Astrana Health (NASDAQ:ASTH) and Sezzle (NASDAQ:SEZL) are both business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.
Astrana Health has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Sezzle has a beta of 9.16, suggesting that its share price is 816% more volatile than the S&P 500.
52.8% of Astrana Health shares are owned by institutional investors. Comparatively, 2.0% of Sezzle shares are owned by institutional investors. 20.0% of Astrana Health shares are owned by insiders. Comparatively, 49.5% of Sezzle shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Sezzle had 1 more articles in the media than Astrana Health. MarketBeat recorded 9 mentions for Sezzle and 8 mentions for Astrana Health. Sezzle's average media sentiment score of 1.02 beat Astrana Health's score of 0.54 indicating that Sezzle is being referred to more favorably in the news media.
Sezzle has lower revenue, but higher earnings than Astrana Health. Astrana Health is trading at a lower price-to-earnings ratio than Sezzle, indicating that it is currently the more affordable of the two stocks.
Astrana Health currently has a consensus price target of $53.29, indicating a potential upside of 129.29%. Sezzle has a consensus price target of $108.28, indicating a potential downside of 28.02%. Given Astrana Health's higher possible upside, equities research analysts plainly believe Astrana Health is more favorable than Sezzle.
Sezzle has a net margin of 32.42% compared to Astrana Health's net margin of 1.56%. Sezzle's return on equity of 114.37% beat Astrana Health's return on equity.
Summary
Sezzle beats Astrana Health on 12 of the 16 factors compared between the two stocks.
Get Astrana Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Astrana Health Competitors List
Related Companies and Tools
This page (NASDAQ:ASTH) was last updated on 7/25/2025 by MarketBeat.com Staff